Another autoimmunity study of SSc-like disease in Selplg−/− mice found increased serum levels of autoantigens, activated DC and CD4+ T effector cells in the skin, vascular damage, and increased mortality rates in mice due to loss of PSGL-1 (176). This evidence concerns the gene SELPLG and systemic sclerosis.